UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Kinase Fusion Gene:PRKAA2_USP24 |
Kinase Fusion Protein Summary |
Kinase Fusion gene summary |
Kinase Fusion partner gene information | Kinase Fusion gene name: PRKAA2_USP24 | KinaseFusionDB ID: KFG4864 | FusionGDB2.0 ID: KFG4864 | Hgene | Tgene | Gene symbol | PRKAA2 | USP24 | Gene ID | 5563 | 23358 | |
Gene name | protein kinase AMP-activated catalytic subunit alpha 2 | ubiquitin specific peptidase 24 | ||||||||||
Synonyms | AMPK|AMPK2|AMPKa2|PRKAA | - | ||||||||||
Cytomap | 1p32.2 | 1p32.3 | ||||||||||
Type of gene | protein-coding | protein-coding | ||||||||||
Description | 5'-AMP-activated protein kinase catalytic subunit alpha-25'-AMP-activated protein kinase, catalytic alpha-2 chainACACA kinaseAMPK alpha 2AMPK subunit alpha-2AMPK-alpha-2 chainHMGCR kinaseacetyl-CoA carboxylase kinasehydroxymethylglutaryl-CoA reduc | ubiquitin carboxyl-terminal hydrolase 24deubiquitinating enzyme 24ubiquitin specific protease 24ubiquitin thioesterase 24ubiquitin thiolesterase 24ubiquitin-specific processing protease 24 | ||||||||||
Modification date | 20240416 | 20240403 | ||||||||||
UniProtAcc | P54646 | Q9UPU5 | ||||||||||
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000371244, | ENST00000484447, ENST00000294383, ENST00000407756, | |||||||||
Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: PRKAA2 [Title/Abstract] AND USP24 [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | PRKAA2(57111154)-USP24(55541196), # samples:3 |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PRKAA2 | GO:0031669 | cellular response to nutrient levels | 25412657 |
Hgene | PRKAA2 | GO:0042149 | cellular response to glucose starvation | 14651849|18439900|34077757|36732624 |
Hgene | PRKAA2 | GO:1903944 | negative regulation of hepatocyte apoptotic process | 32029622 |
Hgene | PRKAA2 | GO:1904262 | negative regulation of TORC1 signaling | 14651849|18439900|36732624|37079666 |
Hgene | PRKAA2 | GO:1905691 | lipid droplet disassembly | 34077757 |
Hgene | PRKAA2 | GO:1990044 | protein localization to lipid droplet | 34077757 |
Kinase Fusion gene breakpoints across PRKAA2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Kinase Fusion gene breakpoints across USP24 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Kinase Fusion Gene Sample Information |
Kinase Fusion gene information. |
Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
ChimerDB4 | TCGA-EE-A2MD-06A | PRKAA2 | chr1 | 57111154 | USP24 | chr1 | 55541196 |
Top |
Kinase Fusion ORF Analysis |
Kinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
Top |
Kinase Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:57111154/:55541196) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
PRKAA2 | USP24 |
FUNCTION: Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism (PubMed:17307971, PubMed:17712357). In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation (PubMed:17307971, PubMed:17712357). AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators (PubMed:17307971, PubMed:17712357). Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively (PubMed:7959015). Promotes lipolysis of lipid droplets by mediating phosphorylation of isoform 1 of CHKA (CHKalpha2) (PubMed:34077757). Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3 (By similarity). Involved in insulin receptor/INSR internalization (PubMed:25687571). AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160 (By similarity). Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A (PubMed:11554766, PubMed:11518699, PubMed:15866171, PubMed:17711846, PubMed:18184930). Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm (By similarity). In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription (By similarity). Acts as a key regulator of cell growth and proliferation by phosphorylating FNIP1, TSC2, RPTOR, WDR24 and ATG1/ULK1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2 (PubMed:14651849, PubMed:20160076, PubMed:21205641). Also phosphorylates and inhibits GATOR2 subunit WDR24 in response to nutrient limitation, leading to suppress glucose-mediated mTORC1 activation (PubMed:36732624). In response to energetic stress, phosphorylates FNIP1, inactivating the non-canonical mTORC1 signaling, thereby promoting nuclear translocation of TFEB and TFE3, and inducing transcription of lysosomal or autophagy genes (PubMed:37079666). In response to nutrient limitation, promotes autophagy by phosphorylating and activating ATG1/ULK1 (PubMed:21205641). In that process also activates WDR45/WIPI4 (PubMed:28561066). Phosphorylates CASP6, thereby preventing its autoprocessing and subsequent activation (PubMed:32029622). AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it (By similarity). May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it (By similarity). Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin (PubMed:17486097). Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1 (PubMed:12519745, PubMed:20074060). Plays an important role in the differential regulation of pro-autophagy (composed of PIK3C3, BECN1, PIK3R4 and UVRAG or ATG14) and non-autophagy (composed of PIK3C3, BECN1 and PIK3R4) complexes, in response to glucose starvation (By similarity). Can inhibit the non-autophagy complex by phosphorylating PIK3C3 and can activate the pro-autophagy complex by phosphorylating BECN1 (By similarity). Upon glucose starvation, promotes ARF6 activation in a kinase-independent manner leading to cell migration (PubMed:36017701). Upon glucose deprivation mediates the phosphorylation of ACSS2 at 'Ser-659', which exposes the nuclear localization signal of ACSS2, required for its interaction with KPNA1 and nuclear translocation (PubMed:28552616). {ECO:0000250|UniProtKB:Q09137, ECO:0000250|UniProtKB:Q8BRK8, ECO:0000269|PubMed:11518699, ECO:0000269|PubMed:11554766, ECO:0000269|PubMed:12519745, ECO:0000269|PubMed:14651849, ECO:0000269|PubMed:15866171, ECO:0000269|PubMed:17486097, ECO:0000269|PubMed:17711846, ECO:0000269|PubMed:18184930, ECO:0000269|PubMed:20074060, ECO:0000269|PubMed:20160076, ECO:0000269|PubMed:21205641, ECO:0000269|PubMed:25687571, ECO:0000269|PubMed:28552616, ECO:0000269|PubMed:28561066, ECO:0000269|PubMed:32029622, ECO:0000269|PubMed:34077757, ECO:0000269|PubMed:36017701, ECO:0000269|PubMed:36732624, ECO:0000269|PubMed:37079666, ECO:0000269|PubMed:7959015, ECO:0000303|PubMed:17307971, ECO:0000303|PubMed:17712357}. | FUNCTION: Ubiquitin-specific protease that regulates cell survival in various contexts through modulating the protein stability of some of its substrates including DDB2, MCL1 or TP53. Plays a positive role on ferritinophagy where ferritin is degraded in lysosomes and releases free iron. {ECO:0000269|PubMed:23159851, ECO:0000269|PubMed:29695420}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
- Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Top |
Kinase-Substrate Information of PRKAA2_USP24 |
Phosphorylation target of the kinase (phosphosite, 03-17-2024) |
Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
PRKAA2 | P54646 | human | REEP1 | Q9H902 | S152 | SERLRsFsMQDLTTI | |
PRKAA2 | P54646 | human | PLD1 | Q13393 | S505 | GsVkRVTsGPsLGSL | |
PRKAA2 | P54646 | human | HDAC5 | Q9UQL6 | S498 | RPLSRtQsSPLPQsP | |
PRKAA2 | P54646 | human | HIPK2 | Q9H2X6 | S121 | LMRRStVsLLDTYQK | |
PRKAA2 | P54646 | human | ACACA | Q13085 | S80 | LHIRssMsGLHLVkQ | |
PRKAA2 | P54646 | human | TP53BP1 | Q12888 | S1317 | SSLHRtssGtsLSAM | |
PRKAA2 | P54646 | human | HIPK2 | Q9H2X6 | T119 | HNLMRRStVsLLDTY | |
PRKAA2 | P54646 | human | PARP1 | P09874 | S177 | LGFRPEYsAsQLkGF | zf-PARP |
PRKAA2 | P54646 | human | PDHA1 | P08559 | S314 | IQEVRSksDPIMLLk | E1_dh |
PRKAA2 | P54646 | human | EEF2K | O00418 | S398 | DsLPssPssAtPHSQ | |
PRKAA2 | P54646 | human | DUSP1 | P28562 | S334 | AVLDRGTsTTTVFNF | |
PRKAA2 | P54646 | human | CDC27 | P30260 | S379 | NALPRRssRLFtsDs | |
PRKAA2 | P54646 | human | FOXO3 | O43524 | S626 | SLECDMEsIIRSELM | FOXO-TAD |
PRKAA2 | P54646 | human | GLI1 | P08151 | S408 | GPLPRAPsISTVEPk | |
PRKAA2 | P54646 | human | PPP1R12C | Q9BZL4 | S452 | AGLQRsAsssWLEGt | |
PRKAA2 | P54646 | human | PINK1 | Q9BXM7 | S228 | MWNISAGsSSEAILN | |
PRKAA2 | P54646 | human | PDHA1 | P08559 | S295 | RyHGHsMsDPGVsyR | E1_dh |
PRKAA2 | P54646 | human | RPTOR | Q8N122 | S792 | DKMRRAssYSsLNSL | |
PRKAA2 | P54646 | human | SIRT1 | Q96EB6 | T344 | GkLLRNYtQNIDTLE | SIR2 |
PRKAA2 | P54646 | human | PINK1 | Q9BXM7 | S495 | ALLQREAsKRPSARV | Pkinase |
PRKAA2 | P54646 | human | GSDME | O60443 | T6 | __MFAkAtRNFLREV | Gasdermin |
PRKAA2 | P54646 | human | PHF2 | O75151 | S655 | kALRPPtsPGVFGAL | |
PRKAA2 | P54646 | human | HAS2 | Q92819 | T110 | LQSVKRLtYPGIKVV | |
PRKAA2 | P54646 | human | FOXO3 | O43524 | S555 | RALsNsVsNMGLSES | |
PRKAA2 | P54646 | human | HIPK2 | Q9H2X6 | T1114 | APAALGStGTVAHLV | |
PRKAA2 | P54646 | human | CHKA | P35790 | S279 | kKLHKLLsYNLPLEL | Choline_kinase |
PRKAA2 | P54646 | human | FOXO3 | O43524 | T179 | SSPDKRLtLSQIyEW | Forkhead |
PRKAA2 | P54646 | human | FOXO3 | O43524 | S588 | QTLSDSLsGSSLYST | |
PRKAA2 | P54646 | human | PROX1 | Q92786 | S79 | KLLKRANsyEDAMMP | |
PRKAA2 | P54646 | human | PINK1 | Q9BXM7 | S284 | VLRAFTSsVPLLPGA | Pkinase |
PRKAA2 | P54646 | human | BAIAP2 | Q9UQB8 | S366 | ktLPRsssMAAGLER | |
PRKAA2 | P54646 | human | FOXO3 | O43524 | S413 | GLMQRSSsFPYTTKG | |
PRKAA2 | P54646 | human | PRKAA2 | P54646 | T172 | sDGEFLRtsCGsPNy | Pkinase |
PRKAA2 | P54646 | human | KLC4 | Q9NSK0 | S590 | SNMKRAAsLNyLNQP | |
PRKAA2 | P54646 | human | PAK2 | Q13177 | S20 | APPVRMsstIFstGG | |
PRKAA2 | P54646 | human | IKBKB | O14920 | S177 | AkELDQGsLCtsFVG | Pkinase |
PRKAA2 | P54646 | human | REEP2 | Q9BRK0 | S150 | SEkLRsFsMQDLTLI | |
PRKAA2 | P54646 | human | TBC1D1 | Q86TI0 | T596 | AFRRRANtLsHFPIE | |
PRKAA2 | P54646 | human | FOXO3 | O43524 | S399 | DNItLPPsQPsPTGG | |
PRKAA2 | P54646 | human | HDAC5 | Q9UQL6 | S259 | FPLRkTAsEPNLKVR | |
PRKAA2 | P54646 | human | GLI1 | P08151 | S102 | LQTVIRTsPSSLVAF | |
PRKAA2 | P54646 | human | IKBKB | O14920 | S181 | DQGsLCtsFVGTLQy | Pkinase |
PRKAA2 | P54646 | human | TFAP2A | P05549 | S219 | CSVPGRLsLLSsTsk | TF_AP-2 |
PRKAA2 | P54646 | human | TBC1D1 | Q86TI0 | S237 | RPMRKsFsQPGLRSL | |
PRKAA2 | P54646 | human | MFF | Q9GZY8 | S172 | GQLVRNDsLWHRsDs | Miff |
PRKAA2 | P54646 | human | MYC | P01106 | S82 | PLsPsRRsGLCsPSy | Myc_N |
PRKAA2 | P54646 | human | GLI1 | P08151 | T1074 | QRGSsGHtPPPsGPP | |
PRKAA2 | P54646 | human | ARMC10 | Q8N2F6 | S45 | LGIRSsKsAGALEEG |
Biological Network Integration of This Kinase and Substrates (GeneMANIA website) |
Enriched GO biological processes of the phosphorylation target genes of the kinase |
Kinase | GOID | GO term | P.adjust |
PRKAA2 | ID | Description | 0.00e+00 |
PRKAA2 | GO:0036294 | cellular response to decreased oxygen levels | 4.29e-04 |
PRKAA2 | GO:0071453 | cellular response to oxygen levels | 4.29e-04 |
PRKAA2 | GO:2001242 | regulation of intrinsic apoptotic signaling pathway | 4.57e-04 |
PRKAA2 | GO:0097193 | intrinsic apoptotic signaling pathway | 4.57e-04 |
PRKAA2 | GO:0043523 | regulation of neuron apoptotic process | 9.17e-04 |
PRKAA2 | GO:2001233 | regulation of apoptotic signaling pathway | 1.29e-03 |
PRKAA2 | GO:0071456 | cellular response to hypoxia | 1.29e-03 |
PRKAA2 | GO:0051402 | neuron apoptotic process | 1.62e-03 |
PRKAA2 | GO:0045913 | positive regulation of carbohydrate metabolic process | 2.08e-03 |
PRKAA2 | GO:0048596 | embryonic camera-type eye morphogenesis | 2.08e-03 |
PRKAA2 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 2.08e-03 |
PRKAA2 | GO:0036293 | response to decreased oxygen levels | 2.10e-03 |
PRKAA2 | GO:0062197 | cellular response to chemical stress | 2.10e-03 |
PRKAA2 | GO:0062012 | regulation of small molecule metabolic process | 2.76e-03 |
PRKAA2 | GO:0070482 | response to oxygen levels | 2.84e-03 |
PRKAA2 | GO:0032869 | cellular response to insulin stimulus | 2.88e-03 |
PRKAA2 | GO:0048048 | embryonic eye morphogenesis | 2.88e-03 |
PRKAA2 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 2.88e-03 |
PRKAA2 | GO:1901796 | regulation of signal transduction by p53 class mediator | 2.92e-03 |
PRKAA2 | GO:0050679 | positive regulation of epithelial cell proliferation | 2.92e-03 |
PRKAA2 | GO:0031076 | embryonic camera-type eye development | 2.92e-03 |
PRKAA2 | GO:0040029 | epigenetic regulation of gene expression | 3.40e-03 |
PRKAA2 | GO:0051403 | stress-activated MAPK cascade | 3.40e-03 |
PRKAA2 | GO:0031098 | stress-activated protein kinase signaling cascade | 3.58e-03 |
PRKAA2 | GO:0071356 | cellular response to tumor necrosis factor | 3.58e-03 |
PRKAA2 | GO:0045814 | negative regulation of gene expressio | 5.52e-05 |
PRKAA2 | GO:0050678 | regulation of epithelial cell proliferation | 3.83e-03 |
PRKAA2 | GO:0031669 | cellular response to nutrient levels | 3.83e-03 |
PRKAA2 | GO:0140718 | facultative heterochromatin formation | 3.83e-03 |
PRKAA2 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 3.83e-03 |
PRKAA2 | GO:0034599 | cellular response to oxidative stress | 3.88e-03 |
PRKAA2 | GO:1900542 | regulation of purine nucleotide metabolic process | 3.88e-03 |
PRKAA2 | GO:0034612 | response to tumor necrosis factor | 3.88e-03 |
PRKAA2 | GO:0006140 | regulation of nucleotide metabolic process | 3.88e-03 |
PRKAA2 | GO:0032873 | negative regulation of stress-activated MAPK cascade | 3.88e-03 |
PRKAA2 | GO:0070303 | negative regulation of stress-activated protein kinase signaling cascade | 3.88e-03 |
PRKAA2 | GO:0030099 | myeloid cell differentiation | 3.91e-03 |
PRKAA2 | GO:0042149 | cellular response to glucose starvation | 3.91e-03 |
PRKAA2 | GO:0010212 | response to ionizing radiation | 4.00e-03 |
PRKAA2 | GO:0032868 | response to insulin | 4.00e-03 |
PRKAA2 | GO:2001235 | positive regulation of apoptotic signaling pathway | 4.63e-03 |
PRKAA2 | GO:0031668 | cellular response to extracellular stimulus | 4.66e-03 |
PRKAA2 | GO:0062013 | positive regulation of small molecule metabolic process | 4.66e-03 |
PRKAA2 | GO:0010508 | positive regulation of autophagy | 4.85e-03 |
PRKAA2 | GO:1990700 | nucleolar chromatin organization | 4.85e-03 |
PRKAA2 | GO:0018105 | peptidyl-serine phosphorylation | 5.27e-03 |
PRKAA2 | GO:0048511 | rhythmic process | 5.27e-03 |
PRKAA2 | GO:0001666 | response to hypoxia | 5.27e-03 |
PRKAA2 | GO:0051054 | positive regulation of DNA metabolic process | 5.27e-03 |
Top |
Related Drugs to PRKAA2_USP24 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Distribution of the number of studies mentioning PRKAA2-USP24 and kinase inhibitors the PubMed Abstract (04-01-2024) |
Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to PRKAA2_USP24 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Related diseases from the literature mentioned this fusion gene and drug. (PubMed, 04-01-2024) |
MeSH ID | MeSH term |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024) |
Clinical Trials from clinicaltrials.gov (06-17-2024) |
Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |